Quality Project to Evaluate and Validate the FAST-O Rating Scale

Completed

• Conditions: Acute Psychotic Symptoms

• Registration Number: NCT00913731
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this project is to test the reliability of the FAST-O Rating Scale in patients at acute wards or psychiatric intensive care units.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-05
• Study First Submitted: 2009-06-02
• Study First Submitted QC: 2009-06-03
• Study First Posted: 2009-06-04
• Status Verified: 2009-10
• Study Completion: 2009-10
• Last Update Submitted: 2009-10-28
• Last Update Posted: 2009-10-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 111

Inclusion Criteria

• Patients with acute psychotic symptoms attending the acute ward or psychiatric intensive care unit

Exclusion Criteria

• Not applicable

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reliability test of the FAST-O rating scale based on observational symptom ratings of patients with acute psychotic diseases	Each patients symtoms will be rated on 2 occasions, by 2-3 raters, each. First is made within 24 hrs of admission to acute psychiatric care, secondis made 14 +/- 2 days after admittance, or earlier if the patient is discharged.

Trial Locations

Locations (1)

Research Site; 🇸🇪 Ystad, Sweden